AVON MESOTHELIOMA FOUNDATION
fund research into Mesothelioma, we have a cople of projects we have applied for approval but have yet to hear the outcome
Financial health, per its FY2024 accounts
The accounts state that the trustees agreed to maintain a reserve balance of at least £50,000 before spending funds. The document reports no funds materially in deficit and details specific grants awarded for research projects. However, the provided text is limited to the Trustees' Annual Report and does not contain the full financial statements required to assess total income, expenditure, or unrestricted reserves.
What the accounts disclose
“The Trustees had agreed to ensure a balance of £50 000 before spending any money from the AMF funds.” — page 5
Trustees
- John Ellis Harveychair
- Anna Jane Morley
- Deborah Jane Walton
- Dr NAJIB MAHBOOB RAHMAN
- Dr Nick Maskell Professor
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 20/12/2024 | £34k | £46k |
| 20/12/2023 | £15k | £216 |
| 20/12/2022 | £10k | £30k |
| 20/12/2021 | £16k | £432 |
| 20/12/2020 | £12k | £216 |
Common questions
Is AVON MESOTHELIOMA FOUNDATION financially healthy?
Per its FY2024 accounts: The accounts state that the trustees agreed to maintain a reserve balance of at least £50,000 before spending funds. The document reports no funds materially in deficit and details specific grants awarded for research projects. However, the provided text is limited to the Trustees' Annual Report and does not contain the full financial statements required to assess total income, expenditure, or unrestricted reserves.